Neuro 2 Flashcards
explain the pathophysiology of myasthenia gravis
an autoimmune disease, producing antibodies to nicotinic ACh receptors, which interfere with neuromuscular transmission by depleting receptor sites.
immune complexes of anti-ACh receptor IgG and complement are deposited at the post-synaptic membranes.
what drug can cause a transient form of myasthenia gravis?
penicillamine
what is the main clinical feature of myasthenia gravis?
increasing muscular fatigue - weakness on sustained/repeated activity, that improves after rest
which muscle groups are affected by mysathenia gravis, in order of most affected
extra-ocular, bulbar (swallowing, chewing), face, neck, limb girdle, trunk
give some examples of things you can look for to assess mysathenia gravis
ptosis (eyelid droop), diplopia, mysathenic snarl on smiling.
voice fades when asked to count to 50.
what specific test would you carry out to investigate myasthenia gravis?
tensilon test - IV edrophonium given, shows improvement in weakness for about 5 minutes
what might you seen on serology of a patient with myasthenia gravis?
anti-AChR and anti-MUSK antibodies
what eye test might you perform to confirm a diagnosis of myasthenia gravis?
see if ptosis improves by >2mm after ice applied to affected lid for >2 mins
how would you treat myasthenia gravis?
symptom control - anticholinesterase (pyridostigmine).
immunosuppression - prednisolone for relapses ± azathioprine/methotrexate.
thymectomy may be considered.
how does pyridostigmine help treat symptoms of myasthenia gravis? name a possible side effect and how you would treat it.
inhibits acetylcholinesterase enzyme from breaking down ACh - thereby increasing level and duration of action of ACh.
colic, diarrhoea - atropine.
name a gene that causes MND. is this the usual cause?
SOD1.
causes rare familiar MND - most cases are sporadic.
what distinguishes motor neurone disease from MS/polyneuropathies?
NO sensory loss or sphincter disturbance in MND.
affects upper and motor neurones.
what happens to the nervous system in MND? what is the prognosis?
selective loss of neurones in motor cortex, cranial nerve nuclei and anterior horn cells.
relentless and unexplained destruction of these neurones.
most die in 3yrs from respiratory failure due to bulbar palsy and pneumonia.
how could you distinguish MND from myasthenia gravis?
MND never affects eye movement, myasthenia gravis will.
name the 4 clinical patterns of MND
ALS (amyotrophic lateral sclerosis).
progressive bulbar palsy.
progressive muscular atrophy.
primary lateral sclerosis.
describe the features of ALS MND and what part of the CNS it affects.
disease of lateral cortiospinal tracts.
causes weakness with UMN signs and LMN wasting.
progressive spastic tetraparesis with LMN signs and fasciculation.
who should you suspect MND in?
> 40yrs.
stumbling spastic gait, foot drop ± proximal myopathy.
weak grip and shoulder abduction.
give some UMN and LMN signs that may feature in MND
UMN - spasticity, brisk reflexes, upgoing plantars.
LMN - wasting, fasciculation of tongue, abdomen, back, thigh
how would you treat a patient with MND?
antiglutamatergic drugs - riluzole - only drug that slows progression.
for drooling - amitriptyline.
muscle spasticity - beclofen.
give 3 organisms that can trigger Guillain-Barre syndrome
Campylobacter jejuni, CMV, mycoplasma zoster, HIV, EBV
describe the pattern of disease progression seen in Guillain-Barre syndrome
a few weeks after infection, symmetrical ascending muscle weakness starts.
advances quickly - affects all limbs, can lead to paralysis.
progressive phase of up to 4 weeks, followed by recovery
describe the clinical features seen in Guillain-Barre
symmetrical ascending muscle weakness.
proximal muscles more affected e.g. trunk, respiratory, cranial nerves.
pain common (e.g. back limb), but no sensory signs.
autonomic dysfunction - sweating, raised pulse, BP changes, arrhythmias.
if you were to perform lumbar puncture on a patient with Guillain-Barre syndrome, what might you see?
increased protein
how would you treat a patient with Guillain-Barre syndrome?
IV immunoglobulin/plasmapharesis.
heparin to prevent DVT.